Team
A multidisciplinary team trained in the public sector.
A team of nineteen specialists led by physicians, health economists and lawyers with careers at the CSG, IMSS, ISSSTE, the Ministry of Health and INSP.
CEO and founder
Dr. Pedro Oliva Oropeza
Physician (UNAM), Master of Health Sciences with a concentration in health economics (National Institute of Public Health) and PhD in Health Sciences (Universidad Anáhuac). For 12 years he led ISSSTE's health economics and supply control and regulation (SICORA) services: he coordinated the update of the Institutional Medicines Catalogue, procurement planning and the National Programmed Demand, and implemented DRG-based costing of medical care. He represented ISSSTE on the Coordinating Commission for the Negotiation of Medicine Prices and on the General Health Council. He is a tenured professor of Biostatistics and of Epidemiology and Public Health in the medical program at Universidad Anáhuac.
Legal Director and founding partner
Mtro. Ricardo César Oliva Oropeza
Lawyer (UNAM), holds a master's degree in Public Administration from the National Institute of Public Administration (INAP) and a specialization in Human Rights from the Antigua Escuela de Jurisprudencia. He has 20 years of experience in the Legislative Branch, in federal and local public administration and in the private sector. His practice focuses on administrative, regulatory and corporate law. He also teaches Law at university level.
Director, Training Center in Health Technology Assessment, and Technical Advisor
Mtra. Erika Itzel Rivas Oropeza
Specialist in health economics and health technology assessment, with 17 years of experience in Mexico's public health sector. She holds a master's degree in Health Sciences with a concentration in Health Economics from the National Institute of Public Health (INSP) and is a doctoral candidate in Health Sciences at Universidad Anáhuac. She has worked at ISSSTE, the General Health Council (CSG) and IMSS. At the IMSS Finance Directorate, where she worked for 13 years, she developed economic evaluation and budget impact analyses for the inclusion of new medicines and health supplies, and issued recommendations on their financial viability to support efficient selection at the Institute. She has taken part in collegiate bodies, commissions and committees inside and outside IMSS on the economic evaluation of pharmaceutical policies, including the assessment of innovative medicine procurement schemes.
Director of Market Access
Nadia López
Economist with postgraduate training in Health Economics and in Health Communication and Management, with experience in market access, health technology assessment and business development in the health sector. Her career spans the design and coordination of economic evaluations, clinical evidence analysis, access and positioning strategies for health technologies, and the development of commercial opportunities for pharmaceutical products and medical devices. She has experience engaging with healthcare professionals, institutions and strategic partners, combining an analytical, commercial and strategic perspective to drive innovative solutions and facilitate their access to the Mexican market.
Director of Health Economics
Mirra Rivera Hernández, MSc
Master in Health Services Administration and bachelor in Administration and Mathematics, with more than 20 years of professional experience in the health, education, demography and economics sectors. At Grupo Lybb she has led, since 2023, projects in economic evaluation, access to health technologies, evidence generation and value strategies for decision-making. At ISSSTE, from 2013 to 2021, she held management and coordination positions — Head of Services, Coordinator and Deputy Director of Health Assurance — where she led the implementation and operation of the Medical Costing System and the Medical-Financial System (SIMEF), as well as projects on medical resource management, installed-capacity planning, financial analysis and health economics. She represented the Directorate on the Medicines and Equipment Committee of the Institutional Formulary, taking part in the evaluation, inclusion and follow-up of health technologies. She is a guest lecturer in Health Economics in the Quality specialty programme at Hospital Regional Lic. Adolfo López Mateos.